Potent antitumor activity of cabozantinib, a c-MET and VEGFR2 inhibitor, in a colorectal cancer patient-derived tumor explant model
Eun Kee Song, W. M. Tai, Wells A. Messersmith, Stacey Bagby, Alicia Purkey, Kevin S. Quackenbush, Todd M. Pitts, Guoliang Wang, Patrick Blatchford, Rachel Yahn, Jeffrey Kaplan, Aik Choon Tan, Chloe E. Atreya, Gail Eckhardt, Robin K. Kelley, Alan Venook, Eunice L. Kwak, David Ryan, John J. Arcaroli
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Potent antitumor activity of cabozantinib, a c-MET and VEGFR2 inhibitor, in a colorectal cancer patient-derived tumor explant model'. Together they form a unique fingerprint.